Mirum Pharmaceuticals' Growth and Market Potential

Core Viewpoint - Mirum Pharmaceuticals is experiencing significant commercial growth and positive market response, reflected in its stock performance and future prospects [2][5]. Group 1: Company Overview - Mirum Pharmaceuticals is a biopharmaceutical company based in Foster City, California, focusing on therapies for rare liver diseases [1]. - The company has a market capitalization of approximately $4.42 billion, indicating its substantial presence in the biopharmaceutical industry [4]. Group 2: Stock Performance - The stock price of Mirum is currently $89.50, reflecting an increase of approximately 3.38% with a change of $2.93 [2]. - The stock has fluctuated between a low of $82 and a high of $90.07 today, with the latter being its highest price over the past year [3]. - The lowest price for MIRM in the past year was $36.88, showcasing substantial growth [3]. Group 3: Market Sentiment - Robert W. Baird has set a price target of $95 for NASDAQ:MIRM, indicating a potential upside of approximately 6.15% [1][5]. - The trading volume for MIRM is 1,229,452 shares, suggesting active investor interest and engagement [4].